135 related articles for article (PubMed ID: 35301906)
1. Immunoglobulin heavy chain gene rearrangement in heavy chain deposition disease suggests it is a plasma cell disease: a case report.
Rao Q; Xu R; Wan Q
J Int Med Res; 2022 Mar; 50(3):3000605221086428. PubMed ID: 35301906
[TBL] [Abstract][Full Text] [Related]
2. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
3. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
4. A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.
Bonaud A; Bender S; Touchard G; Lacombe C; Srour N; Delpy L; Oblet C; Druilhe A; Quellard N; Javaugue V; Cogné M; Bridoux F; Sirac C
Blood; 2015 Aug; 126(6):757-65. PubMed ID: 26113545
[TBL] [Abstract][Full Text] [Related]
5. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
[TBL] [Abstract][Full Text] [Related]
6. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
[TBL] [Abstract][Full Text] [Related]
7. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.
Soma J; Sato K; Sakuma T; Saito H; Sato H; Sato T; Abbas A; Aucouturier P
Am J Kidney Dis; 2004 Jan; 43(1):E10-6. PubMed ID: 14712467
[TBL] [Abstract][Full Text] [Related]
9. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.
Soma J; Tsuchiya Y; Sakuma T; Sato H
Clin Nephrol; 2008 May; 69(5):383-6. PubMed ID: 18538103
[TBL] [Abstract][Full Text] [Related]
10. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
11. A case of renal γ2 heavy-chain deposition disease accompanied by rapid progressive renal failure.
Chen GT; Liao XH; Yan RY; Li Y; Zhang L
Ir J Med Sci; 2014 Jun; 183(2):319-21. PubMed ID: 23963539
[TBL] [Abstract][Full Text] [Related]
12. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
[TBL] [Abstract][Full Text] [Related]
13. Cutis laxa for diagnosis of γ1-heavy-chain deposition disease: Report of four cases.
Chavarot N; Battistella M; Vignon M; Baron M; Girerd S; Jachiet M; Asli B; Galicier L; Malphettes M
J Dermatol; 2018 Oct; 45(10):1211-1215. PubMed ID: 30035313
[TBL] [Abstract][Full Text] [Related]
14. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
[TBL] [Abstract][Full Text] [Related]
15. Heavy chain deposition disease: an overview.
Oe Y; Soma J; Sato H; Ito S
Clin Exp Nephrol; 2013 Dec; 17(6):771-8. PubMed ID: 23652830
[TBL] [Abstract][Full Text] [Related]
16. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.
Herzenberg AM; Kiaii M; Magil AB
Am J Kidney Dis; 2000 May; 35(5):E25. PubMed ID: 10793054
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin A Heavy Chain Deposition Disease: A Case Report.
Chen Q; Ye JB; Zhong Q
Iran J Kidney Dis; 2021 Dec; 15(6):457-460. PubMed ID: 34930858
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
[TBL] [Abstract][Full Text] [Related]
19. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.
Moulin B; Deret S; Mariette X; Kourilsky O; Imai H; Dupouet L; Marcellin L; Kolb I; Aucouturier P; Brouet JC; Ronco PM; Mougenot B
J Am Soc Nephrol; 1999 Mar; 10(3):519-28. PubMed ID: 10073602
[TBL] [Abstract][Full Text] [Related]
20. Heavy chain deposition disease: the disease spectrum.
Kambham N; Markowitz GS; Appel GB; Kleiner MJ; Aucouturier P; D'agati VD
Am J Kidney Dis; 1999 May; 33(5):954-62. PubMed ID: 10213655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
